Equity Analysis /
United States of America

US : Antares Pharma, Inc. - ATRS | Positive Phase 1 for Adrenal Crisis Drug ATRS-1902 Sets Up 2022 NDA in Potential $100M Market

    Michael Parolari
    Michael Parolari

    Research Associate

    CGS-CIMB
    11 January 2022
    Published by